Empowered Funds, LLC Karuna Therapeutics, Inc. Transaction History

Empowered Funds, LLC

  • $6.17 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 27, 2023
SELL
$176.32 - $240.22 $124,129 - $169,114
-704 Reduced 5.2%
12,839 $2.78 Million
Q1 2023

Apr 05, 2023
BUY
$161.33 - $204.36 $176,656 - $223,774
1,095 Added 8.8%
13,543 $2.46 Million
Q4 2022

Jan 26, 2023
BUY
$191.53 - $236.82 $2.38 Million - $2.95 Million
12,448 New
12,448 $2.45 Million

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Empowered Funds, LLC Portfolio

Follow Empowered Funds, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empowered Funds, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email